Company Filing History:

8 out of 330

Aventis Pharma Deutschland, Gmbh

patents

3 out of 6,662

Hoechst Aktiengesellschaft

Sanofi-a Ventis Deutschland Gmbh

patents

5. 1 out of 18

Hoechst Marion Roussel Deutschland Gmbh

patents

Years Active: 1997-2011

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7982045 - 2'-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them (2011-07-19),

2. 7514582 - 2'-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them (2009-04-07),

3. 6759424 - Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them (2004-07-06),

4. 6756489 - Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same (2004-06-29),

5. 6686395 - 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them (2004-02-03),

6. 6531495 - 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them (2003-03-11),

7. 6521654 - Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them (2003-02-18),

8. 6423712 - 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them (2002-07-23),

9. 6413936 - Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity (2002-07-02),

10. 6399643 - Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom (2002-06-04),

11. 6331552 - Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them (2001-12-18),

12. 6197752 - Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom (2001-03-06),

13. 6034238 - Heterocyclic compounds, their preparation and their use as leucocyte (2000-03-07),

14. 5858994 - Carbohydrate conjugates as inhibitors of cell adhesion (1999-01-12),

15. 5817742 - Polymer-conjugated malonic acid derivatives and their use as medicaments (1998-10-06),

Title: Wolfgang Schmidt: Innovator in Medicinal Chemistry

Introduction

Wolfgang Schmidt is a prominent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 16 patents. His work primarily focuses on developing novel compounds that serve as effective medicaments.

Latest Patents

Among his latest patents are the 2'-substituted 1,1'-biphenyl-2-carboxamides. These compounds are particularly noteworthy for their potential use as antiarrhythmic active compounds. They are designed for the treatment and prophylaxis of atrial arrhythmias, such as atrial fibrillation (AF) and atrial flutter. The detailed processes for their preparation and pharmaceutical applications highlight the innovative nature of his work.

Career Highlights

Wolfgang Schmidt has had a distinguished career, working with notable companies such as Aventis Pharma Deutschland GmbH and Hoechst Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.

Collaborations

Throughout his career, Schmidt has collaborated with esteemed colleagues, including Dirk Seiffge and Volkmar Wehner. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Wolfgang Schmidt's contributions to medicinal chemistry and his innovative patents underscore his role as a leading inventor in the field. His work continues to impact the development of effective treatments for cardiac conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com